|
1
|
Schiff PB and Horwitz SB: Taxol stabilizes
microtubules in mouse fibroblast cells. Proc Natl Acad Sci USA.
77:1561–1565. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Catimel G, Verweij J, Mattijssen V,
Hanauske A, Piccart M, Wanders J, Franklin H, Le Bail N, Clavel M
and Kaye SB: Docetaxel (taxotere): an active drug for the treatment
of patients with advanced squamous cell carcinoma of the head and
neck. Ann Oncol. 5:533–537. 1994.PubMed/NCBI
|
|
3
|
Dreyfuss AI, Clark JR, Norris CM, Rossi
RM, Lucarini JW, Busse PM, Poulin MD, Thornhill L, Costello R and
Posner MR: Docetaxel: an active drug for squamous cell carcinoma of
the head and neck. J Clin Oncol. 14:1672–1678. 1996.PubMed/NCBI
|
|
4
|
Baur M, Kienzer HR, Schweiger J, DeSantis
M, Gerber E, Pont J, Hudec M, Schratter-Sehn AU, Wicke W and
Dittrich C: Docetaxel/cisplatin as first-line chemotherapy in
patients with head and neck carcinoma: a phase II trial. Cancer.
94:2953–29582. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tishler RB, Posner MR, Norris CM Jr,
Mahadevan A, Sullivan C, Goguen L, Wirth LJ, Costello R, Case M,
Stowell S, Sammartino D, Busse PM and Haddad RI: Concurrent weekly
docetaxel and concomitant boost radiation therapy in the treatment
of locally advanced squamous cell cancer of the head and neck. Int
J Radiat Oncol Biol Phys. 15:1036–1044. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Katori H, Tsukuda M and Watai K:
Comparison of hyper-fractionation and conventional fractionation
radiotherapy with concurrent docetaxel, cisplatin and
5-fluorouracil (TPF) chemotherapy in patients with locally advanced
squamous cell carcinoma of the head and neck (SCCHN). Cancer
Chemother Pharmacol. 60:399–406. 2007. View Article : Google Scholar
|
|
7
|
Lorch JH, Goloubeva O, Haddad RI, Cullen
K, Sarlis N, Tishler R, Tan M, Fasciano J, Sammartino DE and Posner
MR; TAX 324 Study Group. Induction chemotherapy with cisplatin and
fluorouracil alone or in combination with docetaxel in locally
advanced squamous-cell cancer of the head and neck: long-term
results of the TAX 324 randomised phase 3 trial. Lancet Oncol.
12:153–159. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Iwao-Koizumi K, Matoba R, Ueno N, Kim SJ,
Ando A, Miyoshi Y, Maeda E, Noguchi S and Kato K: Prediction of
docetaxel response in human breast cancer by gene expression
profiling. J Clin Oncol. 20:422–431. 2005.PubMed/NCBI
|
|
9
|
Holmgren A: Thioredoxin. Annu Rev Biochem.
54:237–271. 1985. View Article : Google Scholar
|
|
10
|
Miyazaki K, Noda N, Okada S, Hagiwara Y,
Miyata M, Sakurabayashi I, Yamaguchi N, Sugimura T, Terada M and
Wakasugi H: Elevated serum level of thioredoxin in patients with
hepatocellular carcinoma. Biotherapy. 11:277–288. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nakamura H, Bai J, Nishinaka Y, Ueda S,
Sasada T, Ohshio G, Imamura M, Takabayashi A, Yamaoka Y and Yodoi
J: Expression of thioredoxin and glutaredoxin, redox-regulating
proteins, in pancreatic cancer. Cancer Detect Prev. 24:53–60.
2000.PubMed/NCBI
|
|
12
|
Grogan TM, Fenoglio-Prieser C, Zeheb R,
Bellamy W, Frutiger Y, Vela E, Stemmerman G, Macdonald J, Richter
L, Gallegos A and Powis G: Thioredoxin, a putative oncogene
product, is overexpressed in gastric carcinoma and associated with
increased proliferation and increased cell survival. Hum Pathol.
31:475–481. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kakolyris S, Giatromanolaki A, Koukourakis
M, Powis G, Souglakos J, Sivridis E, Georgoulias V, Gatter KC and
Harris AL: Thioredoxin expression is associated with lymph node
status and prognosis in early operable non-small cell lung cancer.
Clin Cancer Res. 7:3087–3091. 2001.PubMed/NCBI
|
|
14
|
Raffel J, Bhattacharyya AK, Gallegos A,
Cui H, Einspahr JG, Alberts DS and Powis G: Increased expression of
thioredoxin-1 in human colorectal cancer is associated with
decreased patient survival. J Lab Clin Med. 142:46–51. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kim SJ, Miyoshi Y, Taguchi T, Tamaki Y,
Nakamura H, Yodoi J, Kato K and Noguchi S: High thioredoxin
expression is associated with resistance to docetaxel in primary
breast cancer. Clin Cancer Res. 11:8425–8430. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mitani T, Hoshikawa H, Mori T, Hosokawa T,
Tsukamoto I, Yamaguchi F, Kamitori K, Tokuda M and Mori N: Growth
inhibition of head and neck carcinomas by D-allose. Head Neck.
31:1049–1055. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hoshikawa H, Indo K, Mori T and Mori N:
Mori, enhancement of the radiation effects by D-allose in head and
neck cancer cells. Cancer Lett. 306:60–66. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chung JW, Jeon JH, Yoon SR and Choi I:
Vitamin D3 upregulated protein 1 (VDUP1) is a regulator for redox
signaling and stress-mediated diseases. J Dermatol. 33:662–669.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Han SH, Jeon JH, Ju HR, Jung U, Kim KY,
Yoo HS, Lee YH, Song KS, Hwang HM, Na YS, Yang Y, Lee KN and Choi
I: VDUP1 upregulated by TGF-beta1 and 1,25-dihydorxyvitamin D3
inhibits tumor cell growth by blocking cell-cycle progression.
Oncogene. 22:4035–4046. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ohta S, Lai EW, Pang AL, Brouwers FM, Chan
WY, Eisenhofer G, de Krijger R, Ksinantova L, Breza J, Blazicek P,
Kvetnansky R, Wesley RA and Pacak K: Downregulation of metastasis
suppressor genes in malignant pheochromocytoma. Int J Cancer.
114:139–143. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Butler LM, Zhou X, Xu WS, Scher HI,
Rifkind RA, Marks PA and Richon VM: The histone deacetylase
inhibitor SAHA arrests cancer cell growth, up-regulates
thioredoxin-binding protein-2, and down-regulates thioredoxin. Proc
Natl Acad Sci USA. 99:11700–11705. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ikarashi M, Takahashi Y, Ishii Y, Nagata
T, Asai S and Ishikawa K: Vitamin D3 up-regulated protein 1 (VDUPI)
expression in gastrointestinal cancer and its relation to stage of
disease. Anticancer Res. 22:4045–4048. 2002.PubMed/NCBI
|
|
23
|
de Vos S, Hofmann WK, Grogan TM, Krug U,
Schrage M, Miller TP, Braun JG, Wachsman W, Koeffler HP and Said
JW: Gene expression profile of serial samples of transformed B-cell
lymphomas. Lab Invest. 83:271–285. 2003.PubMed/NCBI
|
|
24
|
Haldar S, Basu A and Croce CM: Bcl2 is the
guardian of microtubule integrity. Cancer Res. 57:229–233.
1997.PubMed/NCBI
|
|
25
|
Naha N, Lee HY, Jo MJ, Chung BC, Kim SH
and Kim MO: Rare sugar D-allose induces programmed cell death in
hormone refractory prostate cancer cells. Apoptosis. 13:1121–1134.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pradier O, Rave-Fränk M, Lehmann J, Lücke
E, Boghun O, Hess CF and Schmidberger H: Effects of docetaxel in
combination with radiation on human head and neck cancer cells
(ZMK-1) and cervical squamous cell carcinoma cells (CaSki). Int J
Cancer. 91:840–845. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mason KA, Kishi K, Hunter N, Buchmiller L,
Akimoto T, Komaki R and Milas L: Effect of docetaxel on the
therapeutic ratio of fractionated radiotherapy in vivo. Clin Cancer
Res. 5:4191–4198. 1999.PubMed/NCBI
|
|
28
|
Mizumachi T, Suzuki S, Naito A,
Carcel-Trullols J, Evans TT, Spring PM, Oridate N, Furuta Y, Fukuda
S and Higuchi M: Increased mitochondrial DNA induces acquired
docetaxel resistance in head and neck cancer cells. Oncogene.
27:831–838. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Khan IA and Ludueña RF: Possible
regulation of the in vitro assembly of bovine brain tubulin by the
bovine thioredoxin system. Biochim Biophys Acta. 1076:289–297.
1991. View Article : Google Scholar
|
|
30
|
Hirose K, Longo DL, Oppenheim JJ and
Matsushima K: Overexpression of mitochondrial manganese superoxide
dismutase promotes the survival of tumor cells exposed to
interleukin-1, tumor necrosis factor, selected anticancer drugs,
and ionizing radiation. FASEB J. 7:361–368. 1993.
|
|
31
|
Lee HC, Kim DW, Jung KY, Park IC, Park MJ,
Kim MS, Woo SH, Rhee CH, Yoo H, Lee SH and Hong SI: Increased
expression of antioxidant enzymes in radioresistant variant from
U251 human glioblastoma cell line. Int J Mol Med. 13:883–887.
2004.PubMed/NCBI
|
|
32
|
Mirkovic N, Voehringer DW, Story MD,
McConkey DJ, McDonnell TJ and Meyn RE: Resistance to
radiation-induced apoptosis in Bcl-2-expressing cells is reversed
by depleting cellular thiols. Oncogene. 15:1461–1470. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sun J, Chen Y, Li M and Ge Z: Role of
antioxidant enzymes on ionizing radiation resistance. Free Rad Biol
Med. 24:586–593. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Furuse S, Adachi M, Ijichi K, Ohta S,
Torigoe S, Nakazawa M, Miura S, Mitsudo K and Tohnai I:
Pre-radiation enhances the cytotoxicity of docetaxel in head and
neck squamous cell carcinoma cells. Oncol Rep. 23:1339–1343.
2010.PubMed/NCBI
|
|
35
|
Yamaguchi F, Takata M, Kamitori K, Nonaka
M, Dong Y, Sui L and Tokuda M: Rare sugar D-allose induces specific
up-regulation of TXNIP and subsequent G1 cell cycle arrest in
hepatocellular carcinoma cells by stabilization of p27kip1. Int J
Oncol. 32:377–385. 2008.PubMed/NCBI
|
|
36
|
Hoshikawa H, Mori T and Mori N: In vitro
and in vivo effects of D-allose: up-regulation of
thioredoxin-interacting protein in head and neck cancer cells. Ann
Otol Rhinol Laryngol. 119:567–571. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Adachi I, Watanabe T, Takashima S,
Narabayashi M, Horikoshi N, Aoyama H and Taguchi T: A late phase II
study of RP56976 (docetaxel) in patients with advanced or recurrent
breast cancer. Br J Cancer. 73:210–216. 1996. View Article : Google Scholar
|
|
38
|
Hirooka K, Miyamoto O, Jinming P, Du Y,
Itano T, Baba T, Tokuda M and Shiraga F: Neuroprotective effects of
D-allose against retinal ischemia-reperfusion injury. Invest
Ophthalmol Vis Sci. 47:1653–1657. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Mizote M, Hirooka K, Fukuda K, Nakamura T,
Itano T and Shiraga F: D-allose as ischemic retina injury inhibitor
during rabbit vitrectomy. Jpn J Ophthalmol. 55:294–300. 2011.
View Article : Google Scholar : PubMed/NCBI
|
